Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Field

Showing results (701-710 of 763) with videos related to

Pageof 77
Sort By:
Stroke|December 9, 2024
Factors Influencing Nerinetide Effect on Infarct Volume in Patients Without Alteplase in the Randomized ESCAPE-NA1 TrialJohanna M Ospel, Mayank Goyal, Bijoy K Menon, et al.
International Journal of Stroke : Official Journal of the International Stroke Society|March 13, 2023
Risk of hemorrhagic transformation with early use of direct oral anticoagulants after acute ischemic stroke: A pooled analysis of prospective studies and randomized trialsAnas Alrohimi, David Z Rose, W Scott Burgin, et al.
Journal of Neurointerventional Surgery|August 14, 2025
Intravenous tenecteplase is associated with a higher incidence of thrombus movement before endovascular treatment for acute ischemic stroke: a secondary analysis of the AcT randomized controlled trialIbrahim Alhabli, Noman Ishaque, Mahesh Kate, et al.
The Lancet. Neurology|January 25, 2025
Apixaban versus aspirin for stroke prevention in people with subclinical atrial fibrillation and a history of stroke or transient ischaemic attack: subgroup analysis of the ARTESiA randomised controlled trialAshkan Shoamanesh, Thalia S Field, Shelagh B Coutts, et al.
JAMA|July 2, 2021
Frequency of Thrombocytopenia and Platelet Factor 4/Heparin Antibodies in Patients With Cerebral Venous Sinus Thrombosis Prior to the COVID-19 PandemicMayte Sánchez van Kammen, Mirjam R Heldner, Justine Brodard, et al.
Stroke|April 21, 2023
Infarcts in a New Territory: Insights From the ESCAPE-NA1 TrialNishita Singh, Petra Cimflova, Johanna Maria Ospel, et al.
Journal of Stroke|February 7, 2024
Global Impact of the COVID-19 Pandemic on Cerebral Venous Thrombosis and MortalityThanh N Nguyen, Muhammad M Qureshi, Piers Klein, et al.
European Stroke Journal|March 12, 2025
Feasibility of telephone and computerized cognitive testing as a secondary outcome in an acute stroke clinical trial: A mixed methods sub-study of the AcT TrialSajeevan Sujanthan, Pugaliya Puveendrakumaran, Katie N Dainty, et al.
Cell|July 3, 2021
Polyamine metabolism is a central determinant of helper T cell lineage fidelityDaniel J Puleston, Francesc Baixauli, David E Sanin, et al.
European Stroke Journal|July 12, 2023
Sex differences in cerebral venous sinus thrombosis after adenoviral vaccination against COVID-19Adrian Scutelnic, Anita van de Munckhof, Katarzyna Krzywicka, et al.
Pageof 77

Showing results (701-710 of 763) with videos related to

Sort By:
Pageof 77
Stroke|December 9, 2024
Factors Influencing Nerinetide Effect on Infarct Volume in Patients Without Alteplase in the Randomized ESCAPE-NA1 TrialJohanna M Ospel, Mayank Goyal, Bijoy K Menon, et al.
International Journal of Stroke : Official Journal of the International Stroke Society|March 13, 2023
Risk of hemorrhagic transformation with early use of direct oral anticoagulants after acute ischemic stroke: A pooled analysis of prospective studies and randomized trialsAnas Alrohimi, David Z Rose, W Scott Burgin, et al.
Journal of Neurointerventional Surgery|August 14, 2025
Intravenous tenecteplase is associated with a higher incidence of thrombus movement before endovascular treatment for acute ischemic stroke: a secondary analysis of the AcT randomized controlled trialIbrahim Alhabli, Noman Ishaque, Mahesh Kate, et al.
The Lancet. Neurology|January 25, 2025
Apixaban versus aspirin for stroke prevention in people with subclinical atrial fibrillation and a history of stroke or transient ischaemic attack: subgroup analysis of the ARTESiA randomised controlled trialAshkan Shoamanesh, Thalia S Field, Shelagh B Coutts, et al.
JAMA|July 2, 2021
Frequency of Thrombocytopenia and Platelet Factor 4/Heparin Antibodies in Patients With Cerebral Venous Sinus Thrombosis Prior to the COVID-19 PandemicMayte Sánchez van Kammen, Mirjam R Heldner, Justine Brodard, et al.
Stroke|April 21, 2023
Infarcts in a New Territory: Insights From the ESCAPE-NA1 TrialNishita Singh, Petra Cimflova, Johanna Maria Ospel, et al.
Journal of Stroke|February 7, 2024
Global Impact of the COVID-19 Pandemic on Cerebral Venous Thrombosis and MortalityThanh N Nguyen, Muhammad M Qureshi, Piers Klein, et al.
European Stroke Journal|March 12, 2025
Feasibility of telephone and computerized cognitive testing as a secondary outcome in an acute stroke clinical trial: A mixed methods sub-study of the AcT TrialSajeevan Sujanthan, Pugaliya Puveendrakumaran, Katie N Dainty, et al.
Cell|July 3, 2021
Polyamine metabolism is a central determinant of helper T cell lineage fidelityDaniel J Puleston, Francesc Baixauli, David E Sanin, et al.
European Stroke Journal|July 12, 2023
Sex differences in cerebral venous sinus thrombosis after adenoviral vaccination against COVID-19Adrian Scutelnic, Anita van de Munckhof, Katarzyna Krzywicka, et al.
Pageof 77